Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the ...
Worldwide, breast cancer deaths are projected to increase by 44%, rising to nearly 1.4 million by 2050 from 764,000 in 2023, ...
Vegetarian-associated ESCC risk (HR 1.93) remained robust after excluding the first four follow-up years and restricting to never-smokers, reducing likelihood of reverse causation and smoking ...
Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers ...
A higher body mass index (BMI) appears to be causally related to a greater risk for vascular-related dementia.
The research team used electronic health records data to divide patients into four groups to track symptoms across different obesity levels.
MedPage Today on MSN
GLP-1 Drugs May Work Differently in Women
Women tended to lose more weight than men, meta-analysis shows ...
Characteristics of sarcopenic obesity (SO), including low calf circumference (CC), handgrip strength (HGS) increased body mass index (BMI) and waist circumference (WC), were associated with an ...
I read with interest the cohort study by Guo et al 1 published in a recent issue of Polish Archives of Internal Medicine, showing that the combination of a high body mass index (BMI) and a high ...
Weight loss triggers biological adaptations, including hormonal shifts, metabolic slowing, neural reward changes, and adipose ...
Research presented at AAAAI 2026 suggests GLP-1 RAs may provide clinical benefits for asthma management in patients with excess body weight.
Genetic predisposition to excess body weight was linked to 15% higher mortality in breast cancer survivors, with more walking needed to offset risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results